Table 4.
Comparison of adverse events and VRWS between 2 groups (n/%).
| Group | n | Incidence of adverse events | VRWS | ||||
|---|---|---|---|---|---|---|---|
| DVT | Bronchiectasis | VAP | ICU-AW | Overall incidence rate | |||
| Observation group | 55 | 2 (3.64) | 2 (3.64) | 1 (1.82) | 1 (1.82) | 6 (10.91) | 53 (96.36) |
| Control group | 55 | 7 (12.73) | 4 (7.27) | 5 (9.09) | 6 (10.91) | 22 (40.00) | 45 (81.82) |
| t | 2.778 | .666 | 2.666 | 3.572 | 9.142 | 6.000 | |
| P | .096 | .415 | .103 | .059 | .003 | .014 | |
DVT = deep venous thrombosis, ICU-AW = intensive care units-acquired weakness, VAP = ventilator-associated pneumonia, VRWS = success rate of ventilator weaning.